Donoghue Forlines’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Donoghue Forlines's AMGN Position: Q2 2026 in Review
Donoghue Forlines sold out of Amgen (AMGN) in Q2 2026, closing a stake of 2,212 shares — an estimated $778K sold.
Donoghue Forlines first reported a position in AMGN in Q2 2019 and held it in 24 quarters. The position peaked at $6.71M in Q2 2019. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Donoghue Forlines reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
- Donoghue Forlines sold 2,212 Amgen shares in Q2 2026, an estimated $778K.
- Donoghue Forlines first reported a position in Amgen in Q2 2019 and held it in 24 quarters.
- Donoghue Forlines's Amgen position peaked at $6.71M in Q2 2019.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.